Skip to content

Clinical trials

Lung Diseases, Interstitial trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Country / region: United States Clear all

194 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20052
20062
20075
20085
20093
20104
20115
20122
20138
20144
20153
201611
201710
20189
20197
202011
202116
202212
202320
202414
202510
202623

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed80
Recruiting54
Terminated21
Active, not recruiting12
Unknown status11
Enrolling by invitation6
Not yet recruiting4
Withdrawn3
Suspended2
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim13
United Therapeutics7
Duke University6
Mayo Clinic6
Columbia University5
GlaxoSmithKline5
National Jewish Health5
Bastiaan Driehuys4
Celgene4
Bristol-Myers Squibb3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial194
Idiopathic Pulmonary Fibrosis45
Pulmonary Fibrosis42
Hypertension, Pulmonary30
Pulmonary Disease, Chronic Obstructive25
Lung Diseases18
Scleroderma, Diffuse18
Scleroderma, Systemic17
Fibrosis13
Pulmonary Arterial Hypertension12

Trials

Showing 1 to 25 of 194. Each trial links to its page on Pharma Observatory.

94 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.